Treatment of infarcts
US6271199A · kind A · utility
33Cited by
2References
24Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Nov 24, 1998 |
| Grant date | Aug 7, 2001 |
| Priority date | — |
| Expiry date | Nov 24, 2018 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P9/10
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
This invention is directed to treating ischemia by administering proteasome inhibitors, ubiquitin pathway inhibitors, agents that interfere with the activation of NF-.kappa.B via the ubiquitin proteasome pathway, or mixtures thereof.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.